Molecure S.A. (MOC.WA)
Molecure S.A., a biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
6.11-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-26.4%
The outlook
Molecure S.A. currently reads as leaning bullish based on strong buy — 1.0 avg of 2 analysts, mixed vs its moving averages, 28% of the way from its 52-week low to high, avg target +104% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendMixed vs its moving averages
52-week range28% of the way from its 52-week low to high
Price targetAvg target +104% vs current price
Analyst price target
~12-month · 2 analysts12.45average target+103.8% vs now
Now 6.11
Low 9.90High 15.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$151.1M
52-wk high
9.04
52-wk low
4.98
50-day avg
5.74
200-day avg
6.38
Trailing P/E
—